Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | SUNIL PHARMACYLikely winner L1₹87,000Qualified B NO 62 SHAHEED UDHAM SINGH NAGAR JALANDHAR PUNJAB 144001 | JALANDHAR | PUNJAB | 144001 | L1 | Qualified MSE, Category: General |
Tender Value
₹42,197
EMD Value
Exempted
Closing Date
11 Jun 2026, 7:00 pmClosed
Inj Semaglutide 0 point 25mg
Inj Semaglutide 0 point 50mg
Inj Semaglutide 1mg
Inj Denosumab 60 mg
Inj Glargine 100 u per MI plus Lixisenatide 0 point 05 mg per ml
9406170
GEM/2026/B/7608634
Two Packet Bid
Inj Semaglutide 0 point 25mg,Inj Semaglutide 0 point 50mg,Inj Semaglutide 1mg,Inj Denosumab 60 mg,I
Hyderabad, Telangana
Total value wise evaluation
BOQ
5 documents required · 5 mandatory
2 yrs
20%
Exempted
Yes
11 Jun 2026
1 Jun 2026
11 Jun 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|---|
| 1 | Inj Semaglutide 0 point 25mg | inj | 8 | No | HYDERABAD | 21 | |
| 2 | Inj Semaglutide 0 point 50mg | inj | 4 | No | HYDERABAD | 21 | - |
| 3 | Inj Semaglutide 1mg | inj | 4 | No | HYDERABAD | 21 | |
| 4 | Inj Denosumab 60 mg | inj | 1 | No | HYDERABAD | 21 | - |
| 5 | Inj Glargine 100 u per MI plus Lixisenatide 0 point 05 mg per ml | inj | 6 | No | HYDERABAD | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9406170.pdf
GEM_BID • 0.11 MB
specification-13_echs_2026-06-01-18-42-11_8b144cef734874e3dab8d8506f850f5d.pdf
BOQ • 0.51 MB
boq_item_sample_file_2026-06-01-18-42-11_3f437955327c3b0062c03bcbe10d9164.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .